Torrent Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call on Audited Financial Results of the Company for quarter and year ended 31st...

�;orrent- Q;, PHARmA

30th May, 2022

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

Dear Sir,

The Manager -Listing Dept., National Stock Exchange oflndia Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai -400 051 (NSE Scrip Code: TORNTPHARM)

Sub.: Transcript of Conference call with Analysts I Investors on Audited Financial

Results for the quarter and year ended 315t March, 2022

In continuation of our letter dated 20-May-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requiremerits) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Audited Financial Results of the Company for the st quarter and year ended 31 March, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/TorrentPharma-Earnings-25May-2022.pdf

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

��- MAHESH AGRAWAL VP (LEGAL) & COMPANY SECRETARY

�

Reg.Office: Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com

TORRENT PHARMACEUTICALS LIMITED GIN : L24230GJ1972PLC002126